Provider
bc-com-pharmprogpolicynotifctn-final-4.10.23-eff-6.1.23.pdf
Documents & Forms Results
Displaying 2501 - 2510 of 3629 results
Provider
QP27-23 Commercial and MHCP Pharmacy Benefit Exclusion for Syfovre™
Program effective Date: Apr 12, 2023
Provider
QP28-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2023
Program effective Date: Apr 12, 2023
Provider
QP29-23 Blue Cross Preferred Genetic Laboratory Program
Program effective Date: Apr 12, 2023
Provider
QP30-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2023
Program effective Date: Apr 12, 2023
Provider
QP31-23 Commercial Pharmacy Benefit Exclusion for Fluticasone-Salmeterol
Program effective Date: Apr 12, 2023
Provider
QP32-23 Review and Update NPI Information
Program effective Date: Apr 12, 2023
Provider
QP33-23 Provider Survey: Training & Development Focusing on Equity in Health Care
Program effective Date: Apr 12, 2023
Provider
QP34-23 Update for New to Market Medical Drugs: Tofersen
Program effective Date: Apr 12, 2023
Provider
QP35-23 Notice of Correction to Ambulance Mileage Reimbursement
Program effective Date: Apr 12, 2023